2024 annual financial data
InMed Pharmaceuticals 2024 Financial results
Direct answer
Revenue was 4,597,730 CAD.
Operating income was -8,134,430 CAD and net income was -7,675,550 CAD.
Operating cash flow was -6,985,832 CAD.
Get free InMed Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 4,597,730 CAD
- Operating income
- -8,134,430 CAD
- Net income
- -7,675,550 CAD
- Operating cash flow
- -6,985,832 CAD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all InMed Pharmaceuticals financial years